Last reviewed · How we verify

NCT06263140

Vitamin D Levels in Non-immediate Drug Hypersensitivity Case-control Study

Completed Last updated 16 February 2024
What this trial tests

trial in Stevens-Johnson Syndrome in 120 participants. Completed in 1 February 2022.

Timeline
30 May 2021
Primary endpoint
15 January 2022
1 February 2022

Quick facts

Lead sponsorChulalongkorn University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment120
Start date30 May 2021
Primary completion15 January 2022
Estimated completion1 February 2022
Sites1 location across Thailand

Conditions studied

Sponsor

Chulalongkorn University

Who can join

15 and older, any sex, with Stevens-Johnson Syndrome or Drug Reaction With Eosinophilia and Systemic Symptom. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Serum vitamin D levels in drug-induced non-immediate reactions

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Stevens-Johnson Syndrome

Currently open trials in the same condition.

Other Chulalongkorn University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06263140.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing